Using Octreotide Scans for Thyroid Cancer Diagnosis
Author Information
Author(s): Christian J A, Cook G J R, Harmer C
Primary Institution: Royal Marsden Hospital
Hypothesis
Can 111In-DTPA0octreotide scintigraphy be an effective diagnostic tool for non-iodine avid metastatic thyroid carcinoma?
Conclusion
The study found that octreotide imaging may be useful for staging and monitoring non-iodine avid thyroid carcinoma.
Supporting Evidence
- 14 out of 18 patients showed positive uptake with 111In-DTPA0octreotide.
- In 8 patients, octreotide imaging was as good as or better than conventional imaging.
- The study suggests that octreotide scintigraphy may provide additional useful information for widespread bone metastases.
Takeaway
Doctors used a special scan to see if it could help find thyroid cancer that doesn't absorb iodine, and it worked for many patients.
Methodology
The study involved 18 patients with non-iodine avid metastatic thyroid carcinoma who underwent 111In-DTPA0octreotide scintigraphy and conventional radiology.
Limitations
The study does not provide a definitive alternative to conventional radiology for staging but suggests additional useful information.
Participant Demographics
Patients included 12 with Hurthle cell carcinoma, 4 with papillary carcinoma, 1 with follicular carcinoma, and 1 with medullary thyroid carcinoma.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website